The change would disrupt longstanding payment arrangements in the pharmaceutical industry, which could lower patients' costs but could also have unintended consequences.
The change would disrupt longstanding payment arrangements in the pharmaceutical industry, which could lower patients' costs but could also have unintended consequences.